Marsh grew underlying sales 5% with 10% profit growth as consulting and Risk offset soft reinsurance rates. I see 16% upside to $216.03 on $11.37 of 2027 profit at 19 times.
Key points
- $2.03 of adjusted profit per share, up 10% in Q3, beat estimates on 5% underlying sales growth.
- Consulting sales up 8% and Risk up 5% offset a 6% dip in small Reinsurance on soft property rates.
- Thrive savings goal raised to $600 million funds hiring and tech as Greensill lawsuit charges end.
The call
Soft insurance pricing is holding back fees, so the market expects slow growth. At $186.54, the stock needs only about $10.08 of 2027 profit on a normal broker multiple of 18.5 times yearly profit.
Quarterly revenue steady through soft rates ($ billions)SEC XBRL facts and Q3 2026 release; Q4 26E and Q1 27E are author's estimates. Oct 15 2026.
I expect more profit than that need. I see $30.31 billion of 2027 sales on 5% underlying growth, meaning sales ignoring currency and deals. I see $11.37 of profit per share as the margin (profit divided by sales) widens to 27.5%.
Target rests on 19 times 2027 profit ($ per share)Author's arithmetic: $11.37 of 2027 profit times multiple. Oct 15 2026.
Valuation
| Step | Figure |
|---|
| 2026 sales estimate | $28.87 billion |
| 2027 sales estimate | $30.31 billion |
| 2027 adjusted profit estimate | $11.37 a share |
| Multiple | 19 times |
| 12-month target | $216.03 a share |
| Nineteen times fits a steady compounder with 5% growth and rising margins. The setup gives about 16% upside to $216.03 against single digit downside at 16 times. That asymmetry supports a buy. | |
Risks
- Property and reinsurance rates stay soft and cut commissions; watch Marsh rate index and Risk growth below 3%.
- Consulting slows after pulled forward success fees; watch Management Consulting growth back to low single digits.
- Thrive savings get reinvested rather than kept; watch adjusted margin flat near 22.7% in coming quarters.
What would change my mind
Flat underlying sales with no margin gain in the next two quarters would show pricing pressure beating productivity gains.